| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 186,880 | 178,993 | 177,249 | 179,841 | | Cost of Revenue | 124,404 | 121,289 | 117,193 | 140,616 | | | Gross Profit | 62,476 | 57,704 | 60,056 | 39,225 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 42,779 | 34,506 | 34,531 | 34,771 | | Non Recurring | 108,090 | (2,687) |
-
|
-
| | Others | 5,697 | 4,162 | 7,445 | 6,523 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (94,090) | 21,723 | 18,080 | (2,069) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,025 | 642 | (471) | (1,884) | | Earnings Before Interest And Taxes | (102,074) | 22,365 | 17,609 | (3,953) | | Interest Expense | (5,753) | 3,020 | 2,733 | 4,708 | | Income Before Tax | (96,321) | 19,345 | 14,876 | (8,661) | | Income Tax Expense | (32,327) | 9,699 | 7,800 | 10,110 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (63,994) | 9,646 | 7,076 | (18,771) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (63,994) | 9,646 | 7,076 | (18,771) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($63,994) | $9,646 | $7,076 | ($18,771) |
|
0.73% Nasdaq 
Income Statement
